ArticleCardio-oncology (London, England)2021

CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin.

Jennifer K Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.